HIMS

A class action lawsuit has been filed against Hims & Hers Health, Inc. alleging securities fraud. The complaint claims the company made materially false statements regarding consumer health data sharing with third-party advertisers, premature prescription charges despite promises of provider consultation, and failed to disclose regulatory scrutiny and potential penalties. Investors who purchased Hims securities between August 4, 2025 and July 29, 2026 are eligible to join the case.

Hims & Hers Health faces a securities class action lawsuit after the FTC alleged the telehealth provider shared consumers' sensitive health information with third-party advertising platforms while claiming to maintain privacy, and deceived users about billing and cancellation practices. The stock declined 14.73% on July 29, 2026, following the FTC announcement. Investors who purchased securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to file lead plaintiff applications.

A class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making false and misleading statements regarding consumer health data sharing with third-party advertising platforms, charging for prescriptions immediately after intake forms despite promising provider consultation, and failing to disclose regulatory scrutiny and potential penalties. Investors who purchased Hims securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to apply as lead plaintiff.